|
1
|
Negm OH, Hamed MR, Schoen RE, Whelan RL,
Steele RJ, Scholefield J, Dilnot EM, Kumara Shantha HM, Robertson
JF and Sewell HF: Human blood autoantibodies in the detection of
colorectal cancer. PLoS One. 11:e01569712016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng W and Fan H: Long non-coding RNA
PANDAR correlates with poor prognosis and promotes tumorigenesis in
hepatocellular carcinoma. Biomed Pharmacother. 72:113–118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deng J, Liang Y, Liu C, He S and Wang S:
The up-regulation of long non-coding RNA AFAP1-AS1 is associated
with the poor prognosis of NSCLC patients. Biomed Pharmacother.
75:8–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Zhang L, Zhang Y and Zhou F:
Increased expression of LncRNA BANCR is associated with clinical
progression and poor prognosis in gastric cancer. Biomed
Pharmacother. 72:109–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Fu Z, Ji C, Gu P, Xu P, Yu N, Kan
Y, Wu X, Shen R and Shen Y: Systematic gene microarray analysis of
the lncRNA expression profiles in human uterine cervix carcinoma.
Biomed Pharmacother. 72:83–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Q, Xu E, Dai J, Liu B, Han Z, Wu J,
Zhang S, Peng B, Zhang Y and Jiang Y: A novel long noncoding RNA
AK001796 acts as an oncogene and is involved in cell growth
inhibition by resveratrol in lung cancer. Toxicol Appl Pharmacol.
285:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui Y, Zhang F, Zhu C, Geng L, Tian T and
Liu H: Upregulated lncRNA SNHG1 contributes to progression of
non-small cell lung cancer through inhibition of miR-101-3p and
activation of Wnt/β-catenin signaling pathway. Oncotarget.
8:17785–17794. 2017.PubMed/NCBI
|
|
11
|
Yan Y, Fan Q, Wang L, Zhou Y, Li J and
Zhou K: LncRNA Snhg1, a non-degradable sponge for miR-338, promotes
expression of proto-oncogene CST3 in primary esophageal cancer
cells. Oncotarget. 8:35750–35760. 2017.PubMed/NCBI
|
|
12
|
Li J, Zhang Z, Xiong L, Guo C, Jiang T,
Zeng L, Li G and Wang J: SNHG1 lncRNA negatively regulates
miR-199a-3p to enhance CDK7 expression and promote cell
proliferation in prostate cancer. Biochem Biophys Res Commun.
487:146–152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jalving M, Heijink DM, Koornstra JJ,
Boersma-van Ek W, Zwart N, Wesseling J, Sluiter WJ, de Vries EG,
Kleibeuker JH and de Jong S: Regulation of TRAIL receptor
expression by β-catenin in colorectal tumours. Carcinogenesis.
35:1092–1099. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rashed HE, Hussein S, Mosaad H, Abdelwahab
MM, Abdelhamid MI, Mohamed SY, Mohamed AM and Fayed A: Prognostic
significance of the genetic and the immunohistochemical expression
of epithelial-mesenchymal-related markers in colon cancer. Cancer
Biomark. 20:107–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji L, Wei Y, Jiang T and Wang S:
Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer
and their relationships to clinicopathologic features and survival.
Int J Clin Exp Pathol. 7:1124–1131. 2014.PubMed/NCBI
|
|
18
|
Senol S, Ceyran AB, Kösemetin D, Gobanoglu
B, Aydin D, Duran EA and Leblebici M: Immunohistochemical profile
of tumor pathways and prognostic significance in colon
adenocarcinomas. J Environ Pathol Toxicol Oncol. 36:29–41. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weijun C, Hailu W, Yushu Z and Zhenqiu C:
Study on expression of long non-coding RNA in colon carcinoma.
Linchuang Zhongliuxue Zazhi. 18:882–886. 2013.
|
|
20
|
Xu X, Chen R, Li Z, Huang N, Wu X, Li S,
Li Y and Wu S: MicroRNA-490-3p inhibits colorectal cancer
metastasis by targeting TGFβR1. BMC Cancer. 15:10232015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Agüero F, Murta-Nascimento C, Gallén M,
Andreu-García M, Pera M, Hernández C, Burón A and Macià F:
Colorectal cancer survival: Results from a hospital-based cancer
registry. Rev Esp Enferm Dig. 104:572–577. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao
SD, Zhang Y, Yang L, Shan W, He Q, et al: Comprehensive genomic
characterization of long non-coding RNAs across human cancers.
Cancer Cell. 28:529–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu X, Feng Y, Zhang D, Zhao SD, Hu Z,
Greshock J, Zhang Y, Yang L, Zhong X, Wang LP, et al: A functional
genomic approach identifies FAL1 as an oncogenic long noncoding RNA
that associates with BMI1 and represses p21 expression in cancer.
Cancer Cell. 26:344–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang W, Thomas B, Flynn RA, Gavzy SJ, Wu
L, Kim SV, Hall JA, Miraldi ER, Ng CP, Rigo F, et al: DDX5 and its
associated lncRNA Rmrp modulate TH17 cell effector functions.
Nature. 528:517–522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang M, Wang W, Li T, Yu X, Zhu Y, Ding
F, Li D and Yang T: Long noncoding RNA SNHG1 predicts a poor
prognosis and promotes hepatocellular carcinoma tumorigenesis.
Biomed Pharmacother. 80:73–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
You J, Fang N, Gu J, Zhang Y, Li X, Zu L
and Zhou Q: Non-coding RNA small nucleolar RNA host gene 1 promote
cell proliferation in nonsmall cell lung cancer. Indian J Cancer.
7:99–102. 2014. View Article : Google Scholar
|
|
27
|
Chaudhry MA: Small nucleolar RNA host
genes and long non-coding RNA responses in directly irradiated and
bystander cells. Cancer Biother Radiopharm. 29:135–141. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sahu D, Hsu CL, Lin CC, Yang TW, Hsu WM,
Ho SY, Juan HF and Huang HC: Co-expression analysis identifies long
noncoding RNA SNHG1 as a novel predictor for event-free survival in
neuroblastoma. Oncotarget. 7:58022–58037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rosenbluh J, Wang X and Hahn WC: Genomic
insights into WNT/β-catenin signaling. Trends Pharmacol Sci.
35:103–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cui J, Zhou X, Liu Y, Tang Z and Romeih M:
Wnt signaling in hepatocellular carcinoma: Analysis of mutation and
expression of beta-catenin, T-cell factor-4 and glycogen synthase
kinase 3-beta genes. J Gastroenterol Hepatol. 18:280–287. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Prasetyanti PR, Zimberlin CD, Bots M,
Vermeulen L, Melo FS and Medema JP: Regulation of stem cell
self-renewal and differentiation by Wnt and Notch are conserved
throughout the adenoma-carcinoma sequence in the colon. Mol Cancer.
12:1262013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Greco A, De Virgilio A, Rizzo MI, Pandolfi
F, Rosati D and de Vincentiis M: The prognostic role of E-cadherin
and β-catenin overexpression in laryngeal squamous cell carcinoma.
Laryngoscope. 126:E148–E155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stoyianni A, Goussia A, Pentheroudakis G,
Siozopoulou V, Ioachim E, Krikelis D, Golfinopoulos V, Cervantes A,
Bobos M, Fotsis T, et al: Immunohistochemical study of the
epithelial-mesenchymal transition phenotype in cancer of unknown
primary: Incidence, correlations and prognostic utility. Anticancer
Res. 32:1273–1281. 2012.PubMed/NCBI
|
|
35
|
MacDonald BT, Tamai K and He X:
Wnt/β-catenin signaling: Components, mechanisms, and diseases. Dev
Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vlad A, Röhrs S, Klein-Hitpass L and
Müller O: The first five years of the Wnt targetome. Cell Signal.
20:795–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Prensner JR, Chen W, Han S, Iyer MK, Cao
Q, Kothari V, Evans JR, Knudsen KE, Paulsen MT, Ljungman M, et al:
The long non-coding RNA PCAT-1 promotes prostate cancer cell
proliferation through cMyc. Neoplasia. 16:900–908. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamamoto K, Lee BJ, Li C, Dubois RL,
Hobeika E, Bhagat G and Zha S: Early B-cell-specific inactivation
of ATM synergizes with ectopic CyclinD1 expression to promote
pre-germinal center B-cell lymphomas in mice. Leukemia.
29:1414–1424. 2015. View Article : Google Scholar : PubMed/NCBI
|
